Skip to main content
Premium Trial:

Request an Annual Quote

Age Labs Gets €1M From Research Council of Norway

NEW YORK (GenomeWeb) – Age Labs, an Oslo-based biomarker discovery company, has been awarded €1 million (about $1.1 million) in R&D funding from the Research Council of Norway to support the development of a unique biomarker for aging.

Specifically, the company is developing a methylated DNA biomarker that will predict all-cause mortality risk and risk of developing certain age-related diseases. The company expects the biomarker to enable pharmaceutical companies to increase the probability of success in clinical trials by providing more accurate risk information about patients participating in the trials.

Age Labs is leading the four-year project, which includes collaborators AbbVie, Fürst Medical Laboratory, the Norwegian Institute of Public Health, and Oslo University.

According to its website, Age Labs applies machine learning techniques on large epigenetic datasets from Norwegian and international biobanks.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.